Form 4: Recursion Pharmaceuticals CFO Michael Secora Reports Changes in Beneficial Ownership
SEC Form 4
Michael Secora, CFO of Recursion Pharmaceuticals, reports a transaction involving the withholding of shares to cover tax obligations related to restricted stock units.
Summary
- On May 15, 2024, Recursion Pharmaceuticals' CFO, Michael Secora, reported changes in beneficial ownership of the company's stock.
- The reported transaction involved the withholding of 11,962 Class A Common Stock shares by the issuer to cover tax obligations related to the net settlement of restricted stock units at a price of $10.01.
- Following the transaction, Secora directly owns 1,219,093 shares of Class A Common Stock.
- Secora also holds various stock options with different exercise prices and vesting schedules.
Sentiment
Score: 5
Explanation: This is a routine filing related to tax obligations and stock option vesting, with no inherently positive or negative implications.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the withholding of shares for tax obligations, which is a common practice.
Key Dates
| Date | Description |
|---|---|
| 02/04/2022 | Date of stock option with an exercise price of $11.40 expiring on 02/04/2032. |
| 03/01/2020 | Start date for vesting of stock option originally for 1,125,000 shares, vesting monthly thereafter. |
| 03/01/2022 | Start date for vesting of stock option, vesting monthly thereafter. |
| 03/01/2023 | Start date for vesting of stock option, vesting monthly thereafter. |
| 03/01/2024 | Start date for vesting of stock option, vesting monthly thereafter. |
| 05/15/2024 | Date of the reported transaction involving the withholding of shares for tax obligations. |
| 05/17/2024 | Date of signature by attorney-in-fact. |
| 02/04/2032 | Expiration date of stock option with an exercise price of $11.40. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.